InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Deykin Aaron. Director active across 1 company, notably Upstream Bio, Inc.. Cumulatively, 3 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €7k. Activity tracked since 2 January 2026. The latest transaction was disclosed on 16 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations